 progress surviv studi earli chronic lymphocyt leukemia natur histori stage chronic lymphocyt leukemia cll patient case evalu diseas progress advanc clinic stage actuari estim event year CI linear trend risk hazard function analysi constant pattern progress lack correl event time diseas progress time-depend variabl clear-cut impact surviv aim subgroup patient low probabl diseas progress death set patient differ propos stage method similar term sampl size surviv rate diseas progress risk choic differ propos arbitrari criteria cll patient present studi overal seri stage patient progress occur